2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Myasthenia Gravis
4
Carcinoma, Hepatocellular
2
Skin Neoplasms
1
Nervous System Diseases
1
Melanoma
1
Hepatitis
1
Colitis
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Interventions
telitacicept
3
fludarabine
3
Prednisone
3
Data Collection
3
Cyclophosphamide
3
Specimen Handling
2
Nivolumab
2
Blood Specimen Collection
2
Antilymphocyte Serum
2
thymoglobulin
1
remdesivir
1
prednylidene
1
human papillomavirus vaccine, L1 type 16, 18
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
apremilast
1
Watchful Waiting
1
Vitamin D
1
Valsartan
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Pyridostigmine Bromide
1
Practice Guidelines as Topic
1
Population Groups
1
Platinum Compounds
1
Plasma Exchange
1
Phlebotomy
1
Peripheral Blood Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Autoimmune Diseases
×
Azathioprine
×
Clear all
NCT03490539
2021-02-03
PROMISE-MG
Duke University
Completed
167 enrolled